Does DRUG or KMDA pay a bigger dividend?

KMDA pays a dividend (5.25% yield), while DRUG has no payments in the available dividend history.

Is DRUG or KMDA more profitable?

KMDA runs the higher net margin — DRUG at 0.00% versus KMDA at 11.60%.

How have DRUG and KMDA total returns compared?

Over the past 5 years, DRUG delivered 6.76% and KMDA delivered 10.36% annualized total return. Past performance doesn't predict future results.

Bright Minds Biosciences Inc. (DRUG) vs Kamada Ltd. (KMDA)

A side-by-side comparison of Bright Minds Biosciences Inc. and Kamada Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DRUG

Bright Minds Biosciences Inc.

$477M

$48.77HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT

KMDA

Kamada Ltd.

$474M

$8.22HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT

Total return — DRUG vs KMDA

growth of $100 · dividends reinvested · last 6y

DRUG +84.4% (+10.7%/yr)KMDA +37.0% (+5.4%/yr)DRUG compounded faster over this window

DRUG KMDA

DRUG vs KMDA: by the numbers

•DRUG is the larger company ($477M vs $474M market cap).
•KMDA is profitable (11.60% net margin) while DRUG runs a net loss (0.00%).
•KMDA pays a dividend (5.25% yield), while DRUG has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	DRUG	KMDA
P/E ratio	N/A	21.69
Forward P/E	N/A	17.21
P/S ratio	N/A	2.47
P/B ratio	2.20	1.76
EV / EBITDA	N/A	10.59
FCF yield	N/A	5.58%

Profitability

Metric	DRUG	KMDA
Gross margin	0.00%	40.82%
Operating margin	0.00%	14.51%
Net margin	0.00%	11.60%
ROE	-8.21%	8.25%
ROIC	-13.15%	6.95%

Dividends

Metric	DRUG	KMDA
Dividend yield	N/A	5.25%
Payout ratio	N/A	110.82%

Growth (annualized)

Metric	DRUG	KMDA
Revenue CAGR (5Y)	N/A	10.59%
EPS CAGR (5Y)	N/A	-1.98%
FCF CAGR (5Y)	N/A	40.37%
Total return CAGR (5Y)	6.76%	10.36%

Frequently asked

Does DRUG or KMDA pay a bigger dividend?: KMDA pays a dividend (5.25% yield), while DRUG has no payments in the available dividend history.
Is DRUG or KMDA more profitable?: KMDA runs the higher net margin — DRUG at 0.00% versus KMDA at 11.60%.
How have DRUG and KMDA total returns compared?: Over the past 5 years, DRUG delivered 6.76% and KMDA delivered 10.36% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DRUG analysis Full KMDA analysis Interactive comparison tool

Dig into the metrics

Kamada P/E ratio Kamada dividend yield Bright Minds Biosciences ROE Kamada ROE Bright Minds Biosciences operating margin Kamada operating margin Bright Minds Biosciences revenue growth Kamada revenue growth Bright Minds Biosciences free cash flow Kamada free cash flow

Bright Minds Biosciences & Kamada appear in these rankings

Highest Dividend Yield Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.